nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—Appetite absent—Metformin—metabolic syndrome X	0.0199	0.0477	CcSEcCtD
Buprenorphine—Respiratory distress—Metformin—metabolic syndrome X	0.0156	0.0374	CcSEcCtD
Buprenorphine—Upset stomach—Metformin—metabolic syndrome X	0.0151	0.0362	CcSEcCtD
Buprenorphine—Heartburn—Metformin—metabolic syndrome X	0.0144	0.0345	CcSEcCtD
Buprenorphine—Rigors—Metformin—metabolic syndrome X	0.0121	0.0291	CcSEcCtD
Buprenorphine—Accidental injury—Metformin—metabolic syndrome X	0.0112	0.0268	CcSEcCtD
Buprenorphine—Ear pain—Metformin—metabolic syndrome X	0.00843	0.0202	CcSEcCtD
Buprenorphine—Injury—Metformin—metabolic syndrome X	0.00783	0.0188	CcSEcCtD
Buprenorphine—Lethargy—Metformin—metabolic syndrome X	0.00734	0.0176	CcSEcCtD
Buprenorphine—Pain in extremity—Metformin—metabolic syndrome X	0.0072	0.0172	CcSEcCtD
Buprenorphine—Migraine—Metformin—metabolic syndrome X	0.00708	0.017	CcSEcCtD
Buprenorphine—Dehydration—Metformin—metabolic syndrome X	0.00669	0.016	CcSEcCtD
Buprenorphine—Abdominal pain upper—Metformin—metabolic syndrome X	0.00657	0.0157	CcSEcCtD
Buprenorphine—Breast disorder—Metformin—metabolic syndrome X	0.0065	0.0156	CcSEcCtD
Buprenorphine—Cramp muscle—Metformin—metabolic syndrome X	0.00648	0.0155	CcSEcCtD
Buprenorphine—Nasopharyngitis—Metformin—metabolic syndrome X	0.00644	0.0154	CcSEcCtD
Buprenorphine—Abdominal distension—Metformin—metabolic syndrome X	0.00626	0.015	CcSEcCtD
Buprenorphine—Influenza—Metformin—metabolic syndrome X	0.00622	0.0149	CcSEcCtD
Buprenorphine—Angina pectoris—Metformin—metabolic syndrome X	0.00606	0.0145	CcSEcCtD
Buprenorphine—Abdominal discomfort—Metformin—metabolic syndrome X	0.00596	0.0143	CcSEcCtD
Buprenorphine—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00578	0.0138	CcSEcCtD
Buprenorphine—Infestation NOS—Metformin—metabolic syndrome X	0.00555	0.0133	CcSEcCtD
Buprenorphine—Infestation—Metformin—metabolic syndrome X	0.00555	0.0133	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00524	0.0126	CcSEcCtD
Buprenorphine—Bradycardia—Metformin—metabolic syndrome X	0.00507	0.0121	CcSEcCtD
Buprenorphine—Rhinitis—Metformin—metabolic syndrome X	0.00499	0.012	CcSEcCtD
Buprenorphine—Hypoaesthesia—Metformin—metabolic syndrome X	0.00495	0.0119	CcSEcCtD
Buprenorphine—Oedema peripheral—Metformin—metabolic syndrome X	0.0049	0.0117	CcSEcCtD
Buprenorphine—Connective tissue disorder—Metformin—metabolic syndrome X	0.00489	0.0117	CcSEcCtD
Buprenorphine—Eye disorder—Metformin—metabolic syndrome X	0.00465	0.0111	CcSEcCtD
Buprenorphine—Cardiac disorder—Metformin—metabolic syndrome X	0.00462	0.0111	CcSEcCtD
Buprenorphine—Flushing—Metformin—metabolic syndrome X	0.00462	0.0111	CcSEcCtD
Buprenorphine—Angiopathy—Metformin—metabolic syndrome X	0.00452	0.0108	CcSEcCtD
Buprenorphine—Immune system disorder—Metformin—metabolic syndrome X	0.0045	0.0108	CcSEcCtD
Buprenorphine—Mediastinal disorder—Metformin—metabolic syndrome X	0.00449	0.0107	CcSEcCtD
Buprenorphine—Chills—Metformin—metabolic syndrome X	0.00447	0.0107	CcSEcCtD
Buprenorphine—Malnutrition—Metformin—metabolic syndrome X	0.00433	0.0104	CcSEcCtD
Buprenorphine—Erythema—Metformin—metabolic syndrome X	0.00433	0.0104	CcSEcCtD
Buprenorphine—Flatulence—Metformin—metabolic syndrome X	0.00427	0.0102	CcSEcCtD
Buprenorphine—Dysgeusia—Metformin—metabolic syndrome X	0.00424	0.0102	CcSEcCtD
Buprenorphine—Muscle spasms—Metformin—metabolic syndrome X	0.00417	0.00998	CcSEcCtD
Buprenorphine—Vision blurred—Metformin—metabolic syndrome X	0.00408	0.00978	CcSEcCtD
Buprenorphine—Tremor—Metformin—metabolic syndrome X	0.00406	0.00973	CcSEcCtD
Buprenorphine—Ill-defined disorder—Metformin—metabolic syndrome X	0.00402	0.00963	CcSEcCtD
Buprenorphine—Malaise—Metformin—metabolic syndrome X	0.00391	0.00936	CcSEcCtD
Buprenorphine—Syncope—Metformin—metabolic syndrome X	0.00389	0.00931	CcSEcCtD
Buprenorphine—Palpitations—Metformin—metabolic syndrome X	0.00383	0.00917	CcSEcCtD
Buprenorphine—Loss of consciousness—Metformin—metabolic syndrome X	0.00381	0.00913	CcSEcCtD
Buprenorphine—Hypertension—Metformin—metabolic syndrome X	0.00374	0.00896	CcSEcCtD
Buprenorphine—Chest pain—Metformin—metabolic syndrome X	0.00369	0.00884	CcSEcCtD
Buprenorphine—Myalgia—Metformin—metabolic syndrome X	0.00369	0.00884	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00366	0.00878	CcSEcCtD
Buprenorphine—Discomfort—Metformin—metabolic syndrome X	0.00365	0.00873	CcSEcCtD
Buprenorphine—Oedema—Metformin—metabolic syndrome X	0.00354	0.00847	CcSEcCtD
Buprenorphine—Infection—Metformin—metabolic syndrome X	0.00351	0.00842	CcSEcCtD
Buprenorphine—Shock—Metformin—metabolic syndrome X	0.00348	0.00834	CcSEcCtD
Buprenorphine—Nervous system disorder—Metformin—metabolic syndrome X	0.00347	0.00831	CcSEcCtD
Buprenorphine—Skin disorder—Metformin—metabolic syndrome X	0.00344	0.00823	CcSEcCtD
Buprenorphine—Hyperhidrosis—Metformin—metabolic syndrome X	0.00342	0.00819	CcSEcCtD
Buprenorphine—Anorexia—Metformin—metabolic syndrome X	0.00337	0.00808	CcSEcCtD
Buprenorphine—Hypotension—Metformin—metabolic syndrome X	0.00331	0.00792	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00322	0.00772	CcSEcCtD
Buprenorphine—Paraesthesia—Metformin—metabolic syndrome X	0.00318	0.00761	CcSEcCtD
Buprenorphine—Dyspnoea—Metformin—metabolic syndrome X	0.00315	0.00755	CcSEcCtD
Buprenorphine—Somnolence—Metformin—metabolic syndrome X	0.00314	0.00753	CcSEcCtD
Buprenorphine—Dyspepsia—Metformin—metabolic syndrome X	0.00311	0.00746	CcSEcCtD
Buprenorphine—Decreased appetite—Metformin—metabolic syndrome X	0.00307	0.00737	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00305	0.00732	CcSEcCtD
Buprenorphine—Fatigue—Metformin—metabolic syndrome X	0.00305	0.00731	CcSEcCtD
Buprenorphine—Constipation—Metformin—metabolic syndrome X	0.00302	0.00725	CcSEcCtD
Buprenorphine—Feeling abnormal—Metformin—metabolic syndrome X	0.00291	0.00698	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00289	0.00693	CcSEcCtD
Buprenorphine—Urticaria—Metformin—metabolic syndrome X	0.00281	0.00673	CcSEcCtD
Buprenorphine—Abdominal pain—Metformin—metabolic syndrome X	0.0028	0.0067	CcSEcCtD
Buprenorphine—Asthenia—Metformin—metabolic syndrome X	0.00254	0.00608	CcSEcCtD
Buprenorphine—Pruritus—Metformin—metabolic syndrome X	0.0025	0.00599	CcSEcCtD
Buprenorphine—Diarrhoea—Metformin—metabolic syndrome X	0.00242	0.0058	CcSEcCtD
Buprenorphine—Dizziness—Metformin—metabolic syndrome X	0.00234	0.0056	CcSEcCtD
Buprenorphine—Vomiting—Metformin—metabolic syndrome X	0.00225	0.00539	CcSEcCtD
Buprenorphine—Rash—Metformin—metabolic syndrome X	0.00223	0.00534	CcSEcCtD
Buprenorphine—Dermatitis—Metformin—metabolic syndrome X	0.00223	0.00534	CcSEcCtD
Buprenorphine—Headache—Metformin—metabolic syndrome X	0.00222	0.00531	CcSEcCtD
Buprenorphine—Nausea—Metformin—metabolic syndrome X	0.0021	0.00503	CcSEcCtD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	6.2e-05	0.000106	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	6.17e-05	0.000106	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—LEP—metabolic syndrome X	6.17e-05	0.000106	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—APOE—metabolic syndrome X	6.17e-05	0.000106	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CETP—metabolic syndrome X	6.15e-05	0.000106	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCL2—metabolic syndrome X	6.13e-05	0.000105	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	6.13e-05	0.000105	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PPARA—metabolic syndrome X	6.13e-05	0.000105	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	6.11e-05	0.000105	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CETP—metabolic syndrome X	6.1e-05	0.000105	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—APOA1—metabolic syndrome X	6.1e-05	0.000105	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—SREBF1—metabolic syndrome X	6.07e-05	0.000104	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—TRIB3—metabolic syndrome X	6.06e-05	0.000104	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GOT2—metabolic syndrome X	6.05e-05	0.000104	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—HMGCR—metabolic syndrome X	6.05e-05	0.000104	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ABCA1—metabolic syndrome X	6.04e-05	0.000104	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—SLC2A4—metabolic syndrome X	6.04e-05	0.000104	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IGF1—metabolic syndrome X	6.03e-05	0.000103	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—AGT—metabolic syndrome X	5.93e-05	0.000102	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ALB—metabolic syndrome X	5.91e-05	0.000101	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—HMGCR—metabolic syndrome X	5.9e-05	0.000101	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GOT2—metabolic syndrome X	5.9e-05	0.000101	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	5.89e-05	0.000101	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GGT1—metabolic syndrome X	5.85e-05	0.0001	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GOT1—metabolic syndrome X	5.85e-05	0.0001	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—SCARB1—metabolic syndrome X	5.84e-05	0.0001	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—APOE—metabolic syndrome X	5.81e-05	9.98e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	5.78e-05	9.93e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—APOA1—metabolic syndrome X	5.75e-05	9.86e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—APOB—metabolic syndrome X	5.73e-05	9.83e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SERPINE1—metabolic syndrome X	5.72e-05	9.83e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	5.72e-05	9.81e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	5.68e-05	9.76e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—SREBF1—metabolic syndrome X	5.67e-05	9.73e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—NOS3—metabolic syndrome X	5.65e-05	9.7e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PPARG—metabolic syndrome X	5.57e-05	9.57e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PLA2G4A—metabolic syndrome X	5.57e-05	9.56e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	5.56e-05	9.54e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GOT2—metabolic syndrome X	5.56e-05	9.54e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PPARG—metabolic syndrome X	5.52e-05	9.48e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GOT2—metabolic syndrome X	5.51e-05	9.46e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—HMGCR—metabolic syndrome X	5.51e-05	9.46e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IRS1—metabolic syndrome X	5.5e-05	9.44e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—G6PD—metabolic syndrome X	5.5e-05	9.44e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—LPL—metabolic syndrome X	5.47e-05	9.39e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—INS—metabolic syndrome X	5.47e-05	9.38e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NOS3—metabolic syndrome X	5.47e-05	9.38e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	5.45e-05	9.36e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	5.43e-05	9.33e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—INS—metabolic syndrome X	5.42e-05	9.3e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	5.4e-05	9.27e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—LIPC—metabolic syndrome X	5.4e-05	9.27e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GCK—metabolic syndrome X	5.4e-05	9.27e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—SLC2A4—metabolic syndrome X	5.39e-05	9.25e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ABCA1—metabolic syndrome X	5.39e-05	9.25e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	5.37e-05	9.21e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—APOC3—metabolic syndrome X	5.37e-05	9.21e-05	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—AKT1—metabolic syndrome X	5.34e-05	9.17e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—INS—metabolic syndrome X	5.27e-05	9.04e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ABCA1—metabolic syndrome X	5.26e-05	9.03e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	5.26e-05	9.03e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL6—metabolic syndrome X	5.26e-05	9.02e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—LPA—metabolic syndrome X	5.24e-05	9e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GCKR—metabolic syndrome X	5.24e-05	9e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GOT1—metabolic syndrome X	5.22e-05	8.96e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GGT1—metabolic syndrome X	5.22e-05	8.96e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CETP—metabolic syndrome X	5.21e-05	8.94e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CD36—metabolic syndrome X	5.2e-05	8.92e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCL2—metabolic syndrome X	5.18e-05	8.9e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PTGS2—metabolic syndrome X	5.17e-05	8.87e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IGF1—metabolic syndrome X	5.1e-05	8.75e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GGT1—metabolic syndrome X	5.09e-05	8.74e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GOT1—metabolic syndrome X	5.09e-05	8.74e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	5.08e-05	8.72e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PPARG—metabolic syndrome X	5.06e-05	8.69e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOA5—metabolic syndrome X	5.03e-05	8.63e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ALB—metabolic syndrome X	5.01e-05	8.6e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	4.99e-05	8.56e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	4.97e-05	8.53e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ALB—metabolic syndrome X	4.97e-05	8.53e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—INS—metabolic syndrome X	4.97e-05	8.52e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—APOB—metabolic syndrome X	4.96e-05	8.52e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	4.96e-05	8.51e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	4.96e-05	8.51e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	4.91e-05	8.43e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	4.91e-05	8.43e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	4.86e-05	8.34e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—AKT1—metabolic syndrome X	4.85e-05	8.33e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	4.84e-05	8.31e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SERPINE1—metabolic syndrome X	4.84e-05	8.31e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PPARA—metabolic syndrome X	4.83e-05	8.29e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PLA2G4A—metabolic syndrome X	4.83e-05	8.28e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GOT1—metabolic syndrome X	4.8e-05	8.24e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GGT1—metabolic syndrome X	4.8e-05	8.24e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—NOS3—metabolic syndrome X	4.79e-05	8.23e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GGT1—metabolic syndrome X	4.76e-05	8.17e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GOT1—metabolic syndrome X	4.76e-05	8.17e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—NOS3—metabolic syndrome X	4.75e-05	8.16e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—LPL—metabolic syndrome X	4.74e-05	8.13e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GOT2—metabolic syndrome X	4.71e-05	8.09e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	4.71e-05	8.09e-05	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—AKT1—metabolic syndrome X	4.68e-05	8.04e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—AGT—metabolic syndrome X	4.68e-05	8.03e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	4.67e-05	8.02e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NOS3—metabolic syndrome X	4.62e-05	7.93e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL6—metabolic syndrome X	4.61e-05	7.91e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—APOE—metabolic syndrome X	4.58e-05	7.87e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ALB—metabolic syndrome X	4.55e-05	7.82e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—APOA1—metabolic syndrome X	4.53e-05	7.78e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CD36—metabolic syndrome X	4.5e-05	7.73e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—APOB—metabolic syndrome X	4.43e-05	7.6e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTGS2—metabolic syndrome X	4.38e-05	7.53e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—NOS3—metabolic syndrome X	4.35e-05	7.48e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTGS2—metabolic syndrome X	4.35e-05	7.46e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—APOB—metabolic syndrome X	4.32e-05	7.42e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	4.31e-05	7.39e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—AKT1—metabolic syndrome X	4.25e-05	7.3e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	4.25e-05	7.29e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—LPL—metabolic syndrome X	4.23e-05	7.26e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	4.2e-05	7.22e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	4.2e-05	7.21e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	4.2e-05	7.21e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	4.19e-05	7.2e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PPARA—metabolic syndrome X	4.18e-05	7.18e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—LIPC—metabolic syndrome X	4.17e-05	7.15e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GCK—metabolic syndrome X	4.17e-05	7.15e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOC3—metabolic syndrome X	4.14e-05	7.11e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—LPL—metabolic syndrome X	4.13e-05	7.08e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TGFB1—metabolic syndrome X	4.12e-05	7.08e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—APOB—metabolic syndrome X	4.07e-05	6.99e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GOT1—metabolic syndrome X	4.07e-05	6.98e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GGT1—metabolic syndrome X	4.07e-05	6.98e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—AGT—metabolic syndrome X	4.05e-05	6.96e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—APOB—metabolic syndrome X	4.04e-05	6.93e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CETP—metabolic syndrome X	4.02e-05	6.9e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CD36—metabolic syndrome X	4.02e-05	6.9e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PPARG—metabolic syndrome X	3.99e-05	6.85e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTGS2—metabolic syndrome X	3.98e-05	6.84e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—APOE—metabolic syndrome X	3.97e-05	6.82e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	3.96e-05	6.8e-05	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—AKT1—metabolic syndrome X	3.96e-05	6.79e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	3.93e-05	6.74e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—APOA1—metabolic syndrome X	3.93e-05	6.74e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CD36—metabolic syndrome X	3.92e-05	6.73e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—INS—metabolic syndrome X	3.92e-05	6.72e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6—metabolic syndrome X	3.9e-05	6.69e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—LPL—metabolic syndrome X	3.89e-05	6.68e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—LPL—metabolic syndrome X	3.86e-05	6.62e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	3.85e-05	6.61e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	3.74e-05	6.41e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PPARA—metabolic syndrome X	3.73e-05	6.41e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CD36—metabolic syndrome X	3.7e-05	6.34e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CD36—metabolic syndrome X	3.66e-05	6.29e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PPARA—metabolic syndrome X	3.65e-05	6.26e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GOT2—metabolic syndrome X	3.64e-05	6.24e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	3.64e-05	6.24e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—AGT—metabolic syndrome X	3.62e-05	6.21e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TGFB1—metabolic syndrome X	3.61e-05	6.2e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—AKT1—metabolic syndrome X	3.59e-05	6.17e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ALB—metabolic syndrome X	3.59e-05	6.16e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—APOE—metabolic syndrome X	3.54e-05	6.08e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—AGT—metabolic syndrome X	3.53e-05	6.06e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—APOA1—metabolic syndrome X	3.5e-05	6.01e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—APOE—metabolic syndrome X	3.46e-05	5.94e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PPARG—metabolic syndrome X	3.46e-05	5.94e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—APOB—metabolic syndrome X	3.45e-05	5.92e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PPARA—metabolic syndrome X	3.44e-05	5.9e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—NOS3—metabolic syndrome X	3.43e-05	5.9e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—APOA1—metabolic syndrome X	3.42e-05	5.87e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PPARA—metabolic syndrome X	3.41e-05	5.85e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—INS—metabolic syndrome X	3.39e-05	5.82e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	3.36e-05	5.76e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—AGT—metabolic syndrome X	3.33e-05	5.71e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—AGT—metabolic syndrome X	3.3e-05	5.66e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—LPL—metabolic syndrome X	3.29e-05	5.66e-05	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—AKT1—metabolic syndrome X	3.29e-05	5.64e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—APOE—metabolic syndrome X	3.26e-05	5.6e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	3.24e-05	5.56e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	3.24e-05	5.56e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—APOE—metabolic syndrome X	3.23e-05	5.55e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—APOA1—metabolic syndrome X	3.22e-05	5.53e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—APOA1—metabolic syndrome X	3.19e-05	5.48e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTGS2—metabolic syndrome X	3.14e-05	5.39e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GOT1—metabolic syndrome X	3.14e-05	5.39e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GGT1—metabolic syndrome X	3.14e-05	5.39e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CD36—metabolic syndrome X	3.13e-05	5.37e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ALB—metabolic syndrome X	3.11e-05	5.34e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6—metabolic syndrome X	3.11e-05	5.33e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PPARG—metabolic syndrome X	3.09e-05	5.3e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TGFB1—metabolic syndrome X	3.05e-05	5.24e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—INS—metabolic syndrome X	3.03e-05	5.2e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PPARG—metabolic syndrome X	3.01e-05	5.17e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—NOS3—metabolic syndrome X	2.97e-05	5.11e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—INS—metabolic syndrome X	2.96e-05	5.07e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PPARA—metabolic syndrome X	2.91e-05	5e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—AKT1—metabolic syndrome X	2.87e-05	4.92e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PPARG—metabolic syndrome X	2.84e-05	4.87e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—AGT—metabolic syndrome X	2.82e-05	4.84e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PPARG—metabolic syndrome X	2.81e-05	4.83e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—INS—metabolic syndrome X	2.78e-05	4.78e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ALB—metabolic syndrome X	2.78e-05	4.76e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—APOE—metabolic syndrome X	2.76e-05	4.74e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—INS—metabolic syndrome X	2.76e-05	4.74e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—APOA1—metabolic syndrome X	2.73e-05	4.69e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6—metabolic syndrome X	2.72e-05	4.67e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTGS2—metabolic syndrome X	2.72e-05	4.67e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ALB—metabolic syndrome X	2.71e-05	4.65e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOB—metabolic syndrome X	2.66e-05	4.57e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—NOS3—metabolic syndrome X	2.66e-05	4.56e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—AKT1—metabolic syndrome X	2.6e-05	4.46e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—NOS3—metabolic syndrome X	2.59e-05	4.45e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	2.59e-05	4.45e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ALB—metabolic syndrome X	2.55e-05	4.38e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—LPL—metabolic syndrome X	2.54e-05	4.36e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ALB—metabolic syndrome X	2.53e-05	4.34e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—AKT1—metabolic syndrome X	2.51e-05	4.31e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—NOS3—metabolic syndrome X	2.44e-05	4.19e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	2.43e-05	4.17e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—NOS3—metabolic syndrome X	2.42e-05	4.16e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CD36—metabolic syndrome X	2.42e-05	4.15e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PPARG—metabolic syndrome X	2.41e-05	4.13e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGS2—metabolic syndrome X	2.37e-05	4.07e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—INS—metabolic syndrome X	2.36e-05	4.05e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6—metabolic syndrome X	2.3e-05	3.95e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PPARA—metabolic syndrome X	2.25e-05	3.86e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	2.23e-05	3.83e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	2.21e-05	3.8e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—AKT1—metabolic syndrome X	2.2e-05	3.78e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—AKT1—metabolic syndrome X	2.18e-05	3.75e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—AGT—metabolic syndrome X	2.18e-05	3.73e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ALB—metabolic syndrome X	2.16e-05	3.71e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOE—metabolic syndrome X	2.13e-05	3.66e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—AKT1—metabolic syndrome X	2.12e-05	3.64e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOA1—metabolic syndrome X	2.11e-05	3.62e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—NOS3—metabolic syndrome X	2.07e-05	3.55e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—AKT1—metabolic syndrome X	2e-05	3.44e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	1.89e-05	3.25e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PPARG—metabolic syndrome X	1.86e-05	3.19e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—INS—metabolic syndrome X	1.82e-05	3.13e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ALB—metabolic syndrome X	1.67e-05	2.87e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NOS3—metabolic syndrome X	1.6e-05	2.74e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—AKT1—metabolic syndrome X	1.58e-05	2.71e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	1.46e-05	2.51e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—AKT1—metabolic syndrome X	1.37e-05	2.35e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—AKT1—metabolic syndrome X	1.22e-05	2.1e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—AKT1—metabolic syndrome X	1.19e-05	2.04e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—AKT1—metabolic syndrome X	1.12e-05	1.93e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—AKT1—metabolic syndrome X	1.11e-05	1.91e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—AKT1—metabolic syndrome X	9.51e-06	1.63e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—AKT1—metabolic syndrome X	7.34e-06	1.26e-05	CbGpPWpGaD
